Shattuck Labs (NASDAQ: STTK) net income
Shattuck Labs reported a net loss of $48.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $75.4m. Earnings per share were −$0.70.
Shattuck Labs's best year of the last 7 was fiscal 2019. It reported a loss in 7 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$48.8m | — | −4,880.9% | −$0.70 |
| 2024 | −$75.4m | — | −1,318.1% | −$1.49 |
| 2023 | −$87.3m | — | −5,268.4% | −$2.05 |
| 2022 | −$101.9m | — | −15,635.7% | −$2.41 |
| 2021 | −$45.0m | — | −149.8% | −$1.07 |
| 2020 | −$36.6m | — | −368.5% | −$2.36 |
| 2019 | −$24.0m | — | −242.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Shattuck Labs net income compared with its sector
By net income for its latest fiscal year, Shattuck Labs ranks 253rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Shattuck Labs, −4,880.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 251st | Anavex Life Sciences | −$46.4m | — |
| 252nd | Inhibikase Therapeutics | −$48.3m | — |
| 253rd | Shattuck Labs | −$48.8m | −4,880.9% |
| 254th | Septerna | −$48.9m | −106.4% |
| 255th | Opus Genetics | −$49.6m | −349.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Shattuck Labs
- How much did Shattuck Labs earn in fiscal 2025?
- Shattuck Labs reported a net loss of $48.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $75.4m.
- What are the earnings per share of Shattuck Labs?
- They were −$0.70 in fiscal 2025, compared with −$1.49 in fiscal 2024.
- Where does Shattuck Labs rank in its sector by net income?
- It ranks 253rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Shattuck Labs come from?
- From the annual report (Form 10-K) that Shattuck Labs files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Shattuck Labs files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Shattuck Labs: the Shattuck Labs page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.